RVPH
Reviva Pharmaceuticals Holdi
NASDAQ · Pharmaceuticals
$0.29
+0.03 (+12.35%)
Open$0.26
Previous Close$0.26
Day High$0.31
Day Low$0.26
52W High$15.85
52W Low$6.46
Volume—
Avg Volume227.9K
Market Cap32.96M
P/E Ratio22.80
EPS$0.49
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+4,217.6% upside
Current
$0.29
$0.29
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.36M | 8.56M | 9.00M |
| Net Income | 1.57M | 1.65M | 1.70M |
| Profit Margin | 18.8% | 19.3% | 18.9% |
| EBITDA | 1.64M | 1.79M | 2.00M |
| Free Cash Flow | 1.45M | 1.55M | 1.35M |
| Rev Growth | +3.9% | +2.6% | +16.0% |
| Debt/Equity | 0.31 | 0.31 | 0.40 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |